Jain Aklank, Rajeswari Moganty R, Ahmed Faizan
Department of Biochemistry, All India Institute of Medical Sciences, New Delhi-110029, India.
J Biomol Struct Dyn. 2002 Feb;19(4):691-9. doi: 10.1080/07391102.2002.10506775.
It is well established that GAA/TTC base triplet expansion is the cause of degenerative disorder in Freidreich's Ataxia. It is also known that these repeat sequences fold back to form the unusual intramolecular triple helix structures in DNA of the type Pyrimidine Purine Pyrimidine or Purine PurinePyrimidine. In this paper we report on the stability of Purine PurinePyrimidine intermolecular triple helix DNA containing GAA/TTC repeats under physiological conditions. Using the oligonucleotides 5' TCGC GAA GAA GAA GAA GAA CGCT 3', 5'-AGCG TTC TTC TTC TTC TTC GCGA-3' for duplex and 5'-AAG AAG AAG AAG AAG -3' as triplex forming strand (TFO), we have established the formation of triplex by UV-melting temperature (Tm), stoichiometry of mixing and circular dichroic spectra. This was further confirmed by gel-retardation assay. The thermodynamic parameters Delta G, Delta H and Delta S for both duplex and triplex formation were determined at different salt concentrations. The results suggest the formation of a stable intermolecular, anti - parallel triplex in GAA/TTC repeat sequences where each repeat unit contains two AAT and one GGC triplet. The therapeutic agents and TFOs, which competitively inhibit the in-vivo intra-molecular triplex by formation of a more stable inter-molecular triplex, could be used to reverse the transcription deficit in GAA/TTC expansions in Frataxin gene.
众所周知,GAA/TTC碱基三联体扩增是弗里德赖希共济失调退行性疾病的病因。也已知这些重复序列会折回形成DNA中异常的分子内三螺旋结构,其类型为嘧啶嘌呤嘧啶或嘌呤嘌呤嘧啶。在本文中,我们报道了含有GAA/TTC重复序列的嘌呤嘌呤嘧啶分子间三螺旋DNA在生理条件下的稳定性。使用寡核苷酸5' TCGC GAA GAA GAA GAA GAA CGCT 3'、5'-AGCG TTC TTC TTC TTC TTC GCGA-3'形成双链体,并使用5'-AAG AAG AAG AAG AAG -3'作为三链体形成链(TFO),我们通过紫外熔解温度(Tm)、混合化学计量和圆二色光谱确定了三链体的形成。凝胶阻滞试验进一步证实了这一点。在不同盐浓度下测定了双链体和三链体形成的热力学参数ΔG、ΔH和ΔS。结果表明,在GAA/TTC重复序列中形成了稳定的分子间反平行三链体,其中每个重复单元包含两个AAT和一个GGC三联体。通过形成更稳定的分子间三链体来竞争性抑制体内分子内三链体的治疗剂和TFOs,可用于逆转弗里德赖希共济失调基因中GAA/TTC扩增导致的转录缺陷。